Welcome to our dedicated page for NewAge news (Ticker: NBEV), a resource for investors and traders seeking the latest updates and insights on NewAge stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NewAge's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NewAge's position in the market.
NewAge (Nasdaq: NBEV) has announced a significant breakthrough in health science, isolating a mechanism that blocks spike proteins from binding to human cells. This discovery may enhance immune support and is backed by more than 200 patents and peer-reviewed studies. The company's Tahitian NONI® products, linked to notable health benefits, have generated over $7 billion in sales. The findings were presented at a prestigious conference, indicating strong academic validation. NewAge aims to partner with health organizations to leverage this breakthrough globally.
NewAge, Inc. (Nasdaq: NBEV) has partnered with Kwikclick to launch an innovative affiliate marketing platform that will enhance influencer engagement and social selling. This exclusive agreement allows over 400,000 NewAge Brand Partners to access a global distribution system and leverage Kwikclick's technology, which enables influencers to earn revenue from product sales. The platform is designed to support healthy products and household brands, aiming to transform the influencer model within the consumer goods industry.
NewAge, Inc. (Nasdaq: NBEV) has announced that its Nutrifii Kids™ chewable multivitamins are now included in The Physicians' Desk Reference® (PDR®), a key resource for healthcare providers. This inclusion validates the product's safety and efficacy, enhancing NewAge's reputation for quality. Nutrifii Kids™ is designed to support the healthy development of children, containing essential vitamins and minerals. The PDR® is celebrated for helping health professionals with prescribing decisions, making Nutrifii Kids™ more visible in the medical community.
NewAge, Inc. (Nasdaq: NBEV) reported record financial results for Q2 2021, achieving net revenue of $124 million, a 98% increase year-over-year. The company transitioned from a $9.6 million net loss to a $17.4 million net income, with basic EPS improving to $0.11. Adjusted EBITDA rose to $1.7 million, compared to a loss of $5.5 million in the prior period. Strong performance was attributed to the acquisitions of ARIIX and Aliven, particularly in the European and U.S. markets. The company ended the quarter with $92 million in cash and $31.5 million in debt.
NewAge, Inc. (NBEV) has announced it will release its financial results for the second quarter ending June 30, 2021, on August 9, 2021. The company will hold a conference call at 5:00 p.m. Eastern Time to discuss results and provide updates to investors. Interested parties can participate via a toll-free number or join the webcast available on their investor relations website. The replay of the call will be accessible until August 16, 2021.
NewAge focuses on D2C marketing of organic and healthy products globally.
NewAge, Inc. (Nasdaq: NBEV) announced the appointment of Kevin Manion as Chief Financial Officer. With over two decades of experience, Manion brings expertise from roles at Kraft Heinz, Nestle, and Bolthouse Farms. CEO Brent Willis highlighted Manion's addition as pivotal for scaling operations. Manion expressed excitement about leveraging NewAge's direct-to-consumer model to enhance shareholder value. The company focuses on organic and healthy products globally, operating across three main platforms and employing over 400,000 brand partners.
NewAge, Inc. (Nasdaq: NBEV) has announced a strategic partnership with Taiwan-based TCI Co., Ltd., selling its US manufacturing facility and office for $3.5 million plus revenue sharing over five years. This deal allows NewAge to focus on marketing its health brands while leveraging TCI's manufacturing capabilities to reduce costs and operational expenses. The partnership aims to expand NewAge’s market reach and streamline production, enhancing profitability in 2021. TCI gains a foothold in the US market, increasing its revenue base and global distribution capabilities.
NewAge, Inc. (Nasdaq: NBEV) has been recognized as a five-time award winner in the Hermes Creative Awards for excellence in marketing and corporate image. The awards highlight NewAge's success in direct-to-consumer marketing and creative social media campaigns, particularly for its Lucim™ brand and the NewAge Share™ app. The company reported a 128% year-over-year increase in direct/social selling sales, positioning itself as a leader in the social selling industry and demonstrating its commitment to innovative tools and technologies for its global network of over 400,000 brand partners.
NewAge, Inc. announced its recognition as a double award winner at the 42nd annual Telly Awards, securing Gold and Silver in direct marketing and corporate image categories. This acknowledgement highlights the video ‘Roots + Wings,’ which showcases the merger of NewAge with other brands. The Telly Awards, distinguished in the video and television sector, received over 12,000 entries this year.
